{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:27:02Z","timestamp":1760549222782},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijpharm.2012.04.071","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T07:48:35Z","timestamp":1335858515000},"page":"19-26","source":"Crossref","is-referenced-by-count":11,"title":["A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system"],"prefix":"10.1016","volume":"440","author":[{"given":"Eduardo","family":"Ansorena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkuden","family":"Casales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Tamayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Garbayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Smerdou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Blanco-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria S.","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.04.071_bib0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nbt1109-987","article-title":"What's fueling the biotech engine\u20142008","volume":"27","author":"Aggarwal","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2009.10.015","article-title":"Production of highly pure human glycosylated GDNF in a mammalian cell line","volume":"385","author":"Ansorena","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2005.12.002","article-title":"Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins","volume":"48","author":"Arnau","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1007974121182","article-title":"Recombinant protein production using the Semliki Forest Virus expression system","volume":"24","author":"Blasey","year":"1997","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pharmthera.2008.12.001","article-title":"GDNF\u2014a potential target to treat addiction","volume":"122","author":"Carnicella","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2008.03.016","article-title":"Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability","volume":"376","author":"Casales","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0035","first-page":"459","article-title":"A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model","volume":"26","author":"Ciriza","year":"2008","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jnr.10303","article-title":"Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury","volume":"69","author":"Cheng","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0045","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.copbio.2009.10.008","article-title":"Expression systems for therapeutic glycoprotein production","volume":"20","author":"Durocher","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"issue":"Pt 5","key":"10.1016\/j.ijpharm.2012.04.071_bib0050","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1099\/0022-1317-80-5-1189","article-title":"Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge","volume":"80","author":"Fleeton","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2007.04.003","article-title":"Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor","volume":"344","author":"Garbayo","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0065","first-page":"1","article-title":"Glial cell line-derived neurotrophic factor added to a sciatic nerve fragment grafted in a spinal cord gap ameliorates motor impairments in rats and increases local axonal growth","volume":"27","author":"Guzen","year":"2009","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0070","first-page":"1783","article-title":"Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma","volume":"13","author":"Jiang","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0080","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nbt1291-1356","article-title":"A new generation of animal cell expression vectors based on the Semliki Forest virus replicon","volume":"9","author":"Liljestrom","year":"1991","journal-title":"Biotechnology (N.Y.)"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0085","series-title":"Current Protocols in Molecular Biology","article-title":"Expression of proteins using Semliki Forest virus vectors","author":"Liljestrom","year":"1994"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0090","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0095","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1471-4159.1994.63020758.x","article-title":"Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor","volume":"63","author":"Lin","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0005-2736(02)00721-6","article-title":"Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins","volume":"1610","author":"Lundstrom","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0105","first-page":"503","article-title":"Semliki Forest virus (SFV) vectors in neurobiology and gene therapy","volume":"76","author":"Lundstrom","year":"2003","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0110","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1089\/10430349950017536","article-title":"Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis","volume":"10","author":"Mohajeri","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s004410050695","article-title":"Expression and regulation of glial-cell-line-derived neurotrophic factor (GDNF) mRNA in human astrocytes in vitro","volume":"286","author":"Moretto","year":"1996","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20374","article-title":"Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study","volume":"57","author":"Patel","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymthe.2005.02.011","article-title":"Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas","volume":"12","author":"Rodriguez-Madoz","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/j.1460-2075.1994.tb06337.x","article-title":"Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein","volume":"13","author":"Ryan","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1008006504379","article-title":"Effect of temperature on recombinant protein expression in Semliki Forest virus infected mammalian cell lines growing in serum-free suspension cultures","volume":"28","author":"Schlaeger","year":"1998","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/3-211-30714-1_69","article-title":"Post-traumatic application of brain-derived neurotrophic factor and glia-derived neurotrophic factor on the rat spinal cord enhances neuroprotection and improves motor function","volume":"96","author":"Sharma","year":"2006","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.20861","article-title":"Crossroads in GDNF therapy for Parkinson's disease","volume":"21","author":"Sherer","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nbt1194-1127","article-title":"A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene","volume":"12","author":"Sjoberg","year":"1994","journal-title":"Biotechnology (N.Y.)"},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","article-title":"Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor","volume":"102","author":"Slevin","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0160","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.73.2.1092-1098.1999","article-title":"Two-helper RNA system for production of recombinant Semliki forest virus particles","volume":"73","author":"Smerdou","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0170","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1101\/gad.357006","article-title":"Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR","volume":"20","author":"Ventoso","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2249.1996.11704.x","article-title":"Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy","volume":"104","author":"Wadhwa","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0185","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nbt1252","article-title":"Post-translational modifications in the context of therapeutic proteins","volume":"24","author":"Walsh","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpharm.2012.04.071_bib0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1651-2227.2007.00199.x","article-title":"Glycosylation of therapeutic proteins in different production systems","volume":"96","author":"Werner","year":"2007","journal-title":"Acta Paediatr. Suppl."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312004176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312004176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:35:59Z","timestamp":1594078559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312004176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0378517312004176"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.04.071","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}